Biomaterial Based Stem Cells Therapy for Cancer

Abstract

Biomaterials are developed to aid a variety of regenerative medicine strategies, such as providing a framework for cell adhesion and proliferation or serving as carriers of bioactive factors, while stem cells are increasingly implanted in biomaterial scaffolds to improve therapeutic efficacy. Advanced biomaterials like metals, synthetic polymers, and ceramics are used in bone regeneration technology. The ultimate goal of biomaterial-directed SC (stem cells) culture is to replicate the physical and biochemical characteristics of the physiological SC niche. The primary structural component of tumour ECM (extracellular matrix) is collagen. Cancer initiation, EMT (epithelial-mesenchymal transition), drug resistance, and CSC (cancer stem cells) self-renewal have all been linked to collagen subtypes. The enhancement of liver CSCs has already been investigated using collagen I-based platforms. Alginate and chitosan are two naturally occurring polymers with biological macromolecules that are similar. Biomaterial-based therapies, on the whole, offer incredible versatility and tailorability in the fight against the disease. They could also be used as tissue-engineered scaffolds for immune cell replenishment, potentially making them a key weapon in the next generation of therapeutic approaches.

Keywords: Stem cell therapy; biomaterial; cancer; cancer treatment; collagen; patient care.